• Americans have been told we have no identity, culture, people or country
• The Ethnic American Project:
is a visionary initiative dedicated to recognizing, defining, & revitalizing the distinct ethnic identity of Ethnic Americans, rooted in the historical & legal foundations of the United States as articulated in the Naturalization Act of 1790
• This foundational legislation, one of the first acts of the newly formed U.S. Congress, explicitly outlined the criteria for American citizenship, limiting it to…
“free white persons of good moral character.”
• The Ethnic American Project: seeks to reclaim & formalize this historical identity as a cohesive ethnicity, grounded in shared ancestry, culture, values, & historical experience, while addressing the modern challenges of cultural erosion & loss of identity
• By reestablishing the Ethnic American identity, this project aims to preserve a vital component of the nation’s heritage & foster unity among those who trace their lineage & values to the founding stock of the United States
2) • Ethnic American identity:
is not merely a nostalgic reflection on the past, but a rigorous framework that meets the established anthropological & sociological criteria for an ethnicity
• A combination of shared ancestry, cultural traditions, language, history, & a collective sense of belonging typically defines an ethnicity
• Ethnic Americans:
as defined by the project, fulfill these requirements comprehensively
• Their shared ancestry stems from the predominantly European settlers, largely of:
-Anglo-Saxon
-Celtic
-Germanic
-other European nations
• (unified under the term “White,” these groups joined together to established the United States)
3) • These groups brought with them distinct cultural practices, including:
- a commitment to individual liberty
- self-governance
- a Protestant work ethic
which became the bedrock of American civic & cultural life
• The English language:
shaped by these settlers & their descendants, serves as a unifying linguistic thread, morphed into a unique language itself
• American English is:
detefually different than British English
• This collective history, from the struggles of the colonial era to the triumphs of the American Revolution, to modern war 98% of historical military deaths have been Ethnic American or their ancestors
4) • The Ethnic American Project:
asserts that this identity, while rooted in the 1790 Naturalization Act’s criteria of
“free white persons of good moral character,” transcends mere legalism to encompass a living, breathing cultural & ethnic reality
• The act’s emphasis on
“good moral character”
reflects the values of:
- integrity
- civic responsibility
- & community-mindedness
- that were central to the early American ethos & remain integral to the Ethnic American identity
• These values, combined with a shared heritage & historical experience:
create a cohesive ethnic group that is as valid & vibrant as any other recognized ethnicity in the modern world
5) • Yet, the Ethnic American identity:
has been systematically marginalized, diluted, &, in many ways, stolen from its rightful heirs
• Over time, the forces of globalization, mass immigration, & cultural relativism have eroded the recognition of Ethnic Americans as a distinct group with a unique contribution to the nation’s fabric
• This erosion has led to a crisis of identity, where the descendants of America’s founding peoples are often denied the right to celebrate their heritage or assert their cultural distinctiveness without facing accusations of exclusion or prejudice
• The Ethnic American Project:
contends that this loss of identity is not merely a personal or cultural tragedy, but a threat to the very soul of the nation
6) • The United States, as envisioned by its founders, was built upon the principles, values, & cultural framework of its original settlers
• To lose this identity is to risk losing the foundational ideals that have sustained the nation through centuries of challenges & triumphs
• Reestablishing the Ethnic American identity is, therefore, not an act of division, but a vital step toward national renewal
• By embracing & celebrating this ethnicity, we honor the sacrifices of those who built the nation & ensure that their vision endures for future generations
7) • The Ethnic American Project: calls for a renaissance of pride, unity, & purpose among Ethnic Americans, encouraging them to reclaim their heritage, preserve their cultural legacy, & contribute to a stronger, more cohesive nation
• In a time of uncertainty & division;
the restoration of this identity offers a path forward—a way to reconnect with the principles that made America exceptional & to safeguard its future as a beacon of liberty, opportunity, & unity
• Through education, community-building, & advocacy, the Ethnic American Project seeks to restore what has been lost & to forge a future where Ethnic Americans stand proudly as the soul of America
8) • America is our birthright, founded for Ethnic Americans, the heirs of pioneers who built this Nation for their descendants
• The Ethnic American Project:
reclaims our rich traditions, culture, and heritage
• America for Ethnic Americans
*** IM PROUD TO BE ETHNICALLY AMERICAN ***
@threadreaderapp unroll
• • •
Missing some Tweet in this thread? You can try to
force a refresh
{How Pfizer carried out the biggest pharma trial heist ever & the regulators swallowed it—hook, line, & sinker}
• Evidence Blog By: Arkmedic 10.12.25
• Remember this? (@Jikkyleaks)
“Pfizer’s vaccine is more than 90% effective”
2) • Headlines repeated around the world & more importantly by the regulators FDA, TGA, EMA & MHRA
• The “real” statistic was actually 95%
• Yep, Pfizer & the FDA concluded - after one of the quickest & largest randomized controlled trials in pharma history - that receiving a Pfizer COVID vaccine would give you only 5% of the risk of “catching COVID” than someone who didn’t receive their product
• Just to reiterate - this was about COVID infection
• No claims on severity, hospitalisation or death were made by Pfizer
• The FDA agreed that Pfizer’s trial showed that for every 100 people who were not vaccinated & “got COVID” only 5 vaccinated people would “get COVID”
• & remember this is COVID infection (testing positive), not anything else
• FDA’s analysis of the available efficacy data from 36,523 participants 12 years of age & older without evidence of SARS-CoV-2 infection prior to 7 days after dose 2 confirmed the vaccine was 95% effective (95% credible interval 90.3, 97.6) in preventing COVID-19 occurring at least 7 days after the second dose (with 8 COVID-19 cases in the vaccine group compared to 162 COVID-19 cases in the placebo group)
• Putting this another way, for every vaccinated person you met who had COVID you should have met at least 24 vaccinated people that didn’t ever have COVID
• Given that most of the vaccinated population actually “got COVID” - many of them multiple times, that sounds impossible, right?
• That’s because it was
• Yet the trial nejm.org/doi/full/10.10…
itself showed 95% reduction in the risk of infection & was published in the infamous New England Journal of Medicine (the same journal that published the fraudulent Surgisphere study) on the 10th December 2020 science.org/content/articl…
3) ~ Dates Matter ~
• As a background to the first red flag concerning this trial & subsequent “emergency approval” of the Pfizer COVID-19 vaccine it is worth noting some dates:
• The first patient recruited to the study was July 27th 2020
• By 31st August 2020 half of the participants had been recruited, meaning that less than half the participants had follow-up of at least 75 days from the first injection
• Given that you were supposed to need two weeks after the second injection (35 days) for it to “work” this means that half the participants had follow up of less than 47 days for the “effective dose”
• The original submission from Pfizer to the FDA happened on November 20th 2020
• The “data cut-off” for the trial - the last day that COVID infections could be registered - was November 14th 2020
• The VRBPAC meeting (Vaccines & Related Biological Products Advisory Committee) at the FDA met on the 10th December 2020, the same day the trial was published
• The VRBPAC assessment document for the Pfizer submission was written on the 7th December 2020, just two weeks after the submission was made - & having had to assess a trial with 44,000 participants
• This median of 47 days was the basis on which the approval was given, but it gets worse - much worse
• In fact we are going to show that the whole study was a sham & that there never was a benefit - at all, never mind “95% reduction in infection”
• Here is the chart provided by Pfizer that they used to show that there was a 95% reduction in infection
• It’s impressive
• The red line is the “placebo” group & the blue line is the “vaccinated” group
• And although they initially start off getting infected at the same rate - after about 10 days after the first jab, the vaccinated pretty much stop getting infected at all
• First off, Lyndsey—your story hits like a gut punch & a rallying cry all at once
• Four years of pre-treatment records painting a clear baseline, followed by post-therapy proof of amyloidogenic fibrinogen clot clearance & normalized cytokine levels?
• That's not just data; that's a beacon for every vaccine-injured person dismissed as "anxiety" or "long COVID” overlap
*** You're not just fighting for you—you're the proof-of-concept patient in a protocol that's already showing promise in niche circles ***
• @KevinMcCairnPhD’s amyloid fibrin microclot approach (stem cell growth factors, targeted fibrinolytics, & adjuncts like nattokinase or EDTA chelation) aligns with emerging research on spike protein-induced anomalies
• If replicated, this could rewrite the narrative from "untreatable" to "targetable."
• But will it scale to mass adoption & flip the script on pharma accountability?
• Let's break it down realistically, based on the science, trends, & barriers as of November 2025
~ The Science: Solid Foundation, But Replication Is Key ~
• Your results echo peer-reviewed work on amyloidogenic fibrin microclots—resistant, spike-triggered structures that trap inflammatory cytokines (like IL-6) & evade standard fibrinolysis
• These aren't your garden-variety clots; they're amyloid-like, prion-esque beasts linked to vaccine injury syndromes via S-protein misfolding
• Post-therapy clearance—That's huge—mirroring early trials with "triple" anticoagulants or nattokinase/bromelain/curcumin combos that dissolve these bad boys & drop cytokines
The CCR5 gene encodes a chemokine receptor that plays a critical role in immune cell function, particularly in the recruitment and activation of T-cells and B-cells
Below, I’ll explain how CCR5 influences T-cell and B-cell production, its potential to drive increased production, and the risks associated with chronic overproduction of these cells
1. How CCR5 Impacts T-Cell and B-Cell Production
- Role in Immune Cell Activation and Recruitment:
CCR5 is expressed on T-cells (especially Th1 cells), B-cells, macrophages, and dendritic cells
It binds chemokines (e.g., CCL3, CCL4, CCL5), which guide these cells to sites of infection or inflammation
This signaling enhances the activation and proliferation of T-cells and B-cells by amplifying immune responses
For example, CCR5 signaling can promote T-cell differentiation into effector or memory T-cells and enhance B-cell activation, leading to antibody production
- Stimulation of Proliferation:
CCR5-mediated chemokine signaling can upregulate cytokine production (e.g., IL-2, IFN-γ), which supports T-cell clonal expansion and survival
This indirectly boosts T-cell production in lymphoid organs (e.g., lymph nodes, spleen)
For B-cells, CCR5 signaling enhances their migration to germinal centers, where they undergo proliferation and differentiation into plasma cells for antibody production
This is particularly relevant in response to infections or chronic inflammatory signals
- Microenvironmental Influence:
In lymphoid tissues, CCR5 helps create a microenvironment that supports T-cell and B-cell interactions with antigen-presenting cells (e.g., dendritic cells)
This fosters higher production of activated T- and B-cells during immune responses
2. Mechanisms of Increased T-Cell and B-Cell Production
- Infections and Inflammation:
During infections (e.g., viral respiratory illnesses like influenza or SARS-CoV-2), CCR5 signaling is upregulated due to increased chemokine production
This drives T- and B-cell recruitment and proliferation to combat the pathogen
Chronic infections (e.g., HIV, hepatitis C) can lead to sustained CCR5 activation, resulting in prolonged T- and B-cell production
- Autoimmune and Inflammatory Conditions:
In diseases like rheumatoid arthritis or inflammatory lung conditions (e.g., asthma, COPD), persistent inflammation can maintain high levels of CCR5 ligands, leading to continuous T- and B-cell activation and proliferation
- Genetic Factors:
Variations in CCR5 expression or function (e.g., polymorphisms) can alter the intensity of immune responses
For instance, individuals with normal CCR5 function may experience robust T- and B-cell responses compared to those with the CCR5-Δ32 mutation, which reduces receptor activity
*** COVID Accountability Victory: Court Rules in Favor of Healthcare Whistleblower ***
~ An update on US ex rel. Conrad v. Rochester Regional Health System. ~
By: WARNER MENDENHALL
@MendenhallFirm
JUL 17, 2025
• For 21 years, Deborah Conrad served as a dedicated Physician Assistant
• She was fired from Rochester Regional Health for doing her job - reporting adverse events to protect public safety
• A federal court vindicated her actions and opened the door for accountability
• On June 11, 2025, the U.S. District Court for the Western District of New York issued a landmark ruling for my client, Deborah Conrad, in her case against Rochester Regional Health and United Memorial Medical Center
• Judge Sinatra denied the hospital's motion to dismiss the core claims in Deborah's False Claims Act lawsuit, letting her case go to discovery
• Here's what this means:
The Court Found:
•Rochester Regional Health had a material obligation to report serious adverse events to VAERS under their Provider Agreement with the CDC
•The hospital's failure to report while continuing to seek federal reimbursement was potential fraud against the government
•Deborah's detailed allegations were enough to meet the strict legal standards for fraud claims, even without access to internal billing records
•Her retaliation claim can move forward - the court found she was probably fired for trying to expose the hospital's failure to report adverse events
• This decision establishes critical legal precedents:
1VAERS Reporting is Not Optional:
• The court confirmed that adverse event reporting requirements are "material conditions of payment" - not just bureaucratic paperwork
2Hospitals Can Be Held Accountable:
• Healthcare providers who take federal money while failing to meet safety reporting obligations can face False Claims Act liability
3Whistleblowers Are Protected:
• The court recognized that employees who try to ensure proper adverse event reporting are engaging in protected activity
• Deborah's case involved 170 serious adverse events that the hospital allegedly prevented her from reporting
• 160 VAERS reports she successfully submitted on her own initiative
• Specific patient examples of adverse events following vaccination that went unreported
• The court found these allegations painted a picture of systematic non-compliance with federal safety monitoring requirements
• This ruling is significant beyond just Deborah's case
• It establishes that:
1) healthcare providers cannot ignore federal safety reporting requirements while continuing to collect taxpayer money
2) the False Claims Act can be used to hold institutions accountable for COVID-related misconduct
3) whistleblowers who expose these practices have legal protection
• We estimate over 500,000 were killed by the shots, millions lost their jobs for refusing them, and Big Pharma received billions for dangerous and experimental treatments
• This case reveals a legal pathway to begin holding the system accountable
• The case now moves to discovery, where we will seek the hospital's internal “vaccination,” treatment, and billing records to uncover the full scope of unreported adverse events which we believe are in the 1000s in this hospital system alone covidlawcast.com/p/covid-accoun…
1~ A THREAD EVERY HUMAN BEING NEEDS TO READ & WILL AFFECT EVERY PERSON ON THIS PLANET REGARDLESS OF VACCINE STATUS ~
~> Amyloidogenic Fibrin Microclotting Following Prenatal mRNA Vaccination Exposure <~
*** HOUSTON, WE HAVE A PROBLEM ***
(@KevinMcCairnPhD)
05.24.25 at 20:59
2~ PREAMBLE: Houston, WE HAVE A PROBLEM!
•Scientific investigations involving emerging & potentially paradigm-shifting findings often walk a difficult line between the need for caution & the imperative to inform
• While early publication of case studies carries inherent risks—such as overinterpretation of individual data points or lack of statistical power—it also provides critical, time-sensitive insights that can drive new lines of inquiry & inform ongoing clinical & public health departments
• This report forms part of a robust, real-time investigation into the proteopathic & vascular consequences of prenatal exposure to mRNA-based SARS-COV-2 “vaccines”
• The intention is not to draw definitive epidemiological conclusions at this stage, but to publicly document the emergence of novel findings as they occur
• This transparent approach is particularly important in areas where existing safety literature has not yet integrated proteomic misfolding or amyloidogenic biomarker screening into its framework
• This investigative format mirrors the best practices seen in real-time pathogen tracking & pharmacovigilance
• In such contexts, timelines & transparency are essential for mitigating long-term risk & prompting refinement of public health frameworks